Acquisition of 100% of the share capital of Wentimed, founded by Dr. Piotr Compała, specialized in home treatments of mechanical ventilation and palliative care.
SOL Group, a multinational company operating in the technical, industrial, and medical gases sector and in the home care sector under the "VIVISOL" brand, announces that it has strengthened its position in Poland with the acquisition of 100% of Wentimed.
Founded in 2014 by Dr. Piotr Compała, who has led its growth by fostering rapid and significant development, in 2025 Wentimed achieved a total turnover of more than PLN 40 million (over EUR 9 million) and currently employs more than 100 internal and external staff. Dr. Compała will continue to work in Wentimed alongside SOL for the transition phase.
More details in the Press Release.
tags:
share:
